Paper66477
Intrathymic pathogenesis and dual genetic control of myasthenia gravis.
Wekerle H and 1 other. Lancet, 1977. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Papers, record 66477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myasthenia Gravis | Major topic |
| Animals | |
| Antibody Formation | |
| Antigen-Antibody Reactions | |
| Autoantibodies | |
| Autoantigens | |
| Autoimmune Diseases | |
| Cell Differentiation | |
| Clone Cells | |
| Culture Techniques | |
| Genes, Regulator | |
| HLA Antigens | |
| Hematopoietic Stem Cells | |
| Mice | |
| Muscles | |
| Rats | |
| T-Lymphocytes | |
| Thymus Gland |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39736788 | The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases. | Biomark Res | 2024 | https://conductscience.org/library/papers/39736788 | PubMed |
| 33537838 | Thymus and autoimmunity. | Semin Immunopathol | 2021 | https://conductscience.org/library/papers/33537838 | PubMed |
| 22551731 | Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. | Neurology | 2012 | https://conductscience.org/library/papers/22551731 | PubMed |
| 21180568 | Progress in the treatment of myasthenia gravis. | Ther Adv Neurol Disord | 2008 | https://conductscience.org/library/papers/21180568 | PubMed |
| 19019304 | Current and future standards in treatment of myasthenia gravis. | Neurotherapeutics | 2008 | https://conductscience.org/library/papers/19019304 | PubMed |
| 17675582 | Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17675582 | PubMed |
| 12925692 | Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12925692 | PubMed |
| 9590719 | Malignant thymoma with direct invasion into the peritoneal cavity: report of a case. | Surg Today | 1998 | https://conductscience.org/library/papers/9590719 | PubMed |
| 9259176 | Current and future therapies for myasthenia gravis. | Drugs Aging | 1997 | https://conductscience.org/library/papers/9259176 | PubMed |
| 8623907 | Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. | Am J Pathol | 1996 | https://conductscience.org/library/papers/8623907 | PubMed |
| 8536358 | 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies. | Clin Exp Immunol | 1995 | https://conductscience.org/library/papers/8536358 | PubMed |
| 8094093 | Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis. | J Neurol Neurosurg Psychiatry | 1993 | https://conductscience.org/library/papers/8094093 | PubMed |
| 7943168 | Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells. | Am J Pathol | 1994 | https://conductscience.org/library/papers/7943168 | PubMed |
| 7512979 | Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. | J Clin Invest | 1994 | https://conductscience.org/library/papers/7512979 | PubMed |
| 6794741 | Pathogenesis and treatment of myasthenia gravis. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6794741 | PubMed |
| 6342809 | Establishment of a myoid cell clone from rat thymus. | Cell Tissue Res | 1983 | https://conductscience.org/library/papers/6342809 | PubMed |
| 3486818 | Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants. | Immunology | 1986 | https://conductscience.org/library/papers/3486818 | PubMed |
| 2466050 | Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2466050 | PubMed |
| 2459161 | A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2459161 | PubMed |
| 2449461 | Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2449461 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/66477
GET https://conductscience.org/api/papers/v1/66477/cited_by?page=2